IDSA and HIVMA welcome the president's extension of his projected duration for stay-at-home and physical distancing guidelines to last at least through April based on public health guidance, while calling for continued commitment to data-driven responses to the coronavirus.
In the midst of the new global health threat posed by COVID-19, this World TB Day reminds us that global efforts to control the world’s leading infectious disease killer must be accelerated to rid us of our oldest pandemic.
Infectious disease and HIV physicians, healthcare epidemiologists and other medical professionals on the frontlines defending our country from COVID-19 urgently need equipment and supplies to protect themselves, identify infections, treat patients, and save lives.
With attention to diagnostic, treatment, health care and community needs that must be met if we are to reverse the trajectory of COVID-19 spread in the United States, the Coronavirus Aid, Relief, and Economic Security Act addresses some of the most critical challenges facing our country in the weeks and months ahead.
The Infectious Diseases Society of America has developed recommendations for public health and health care professionals to prioritize testing for COVID-19 during the shortage of accessible tests and the continuing spread of the virus.
President Trump’s fiscal year 2021 budget plan proposes $716 million in funding for the Ending the HIV Epidemic initiative – more than double the 2020 request.
Today Rep. John Lewis introduced the H.R. 5806, HIV Epidemic Loan-Repayment Program (HELP) Act with Rep. Barbara Lee and Rep. Frederica Wilson as original co-sponsors.
The U.S. Supreme Court’s decision to allow new “Public Charge” rules to take effect in the midst of legal challenges to this the radical policy change
The National Academy of Medicine report released Thursday, Opportunities to Improve Opioid Use Disorder and Infectious Disease Services: Integrating Responses to a Dual Epidemic,
Information to help clinics and clinicians prepare for delivery system, staffing and administrative changes that may be needed for providing access to long-acting ARV treatment.
The bill provides $241 million in new funding for the administration’s Ending the HIV Epidemic initiative.
H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act passed by the House of Representatives today introduces critically needed and significant steps to reduce costs and improve access to life-saving therapies
